We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Hormone Therapy Use and Outcomes in the Women’s Health Initiative Trials—Reply

JoAnn E. Manson, MD, DrPH1; Rowan T. Chlebowski, MD, PhD2; Aaron K. Aragaki, MS3
[+] Author Affiliations
1Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts
2Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California
3Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington
JAMA. 2014;311(4):417-418. doi:10.1001/jama.2013.285163.
Text Size: A A A
Published online


In Reply Dr Roehm requests more information about the gallbladder disease outcome in the WHI trials. The goal of our article was to provide a comprehensive, integrated overview of findings from the 2 hormone therapy trials, including results from extended postintervention follow-up.

Due to the large number of outcomes presented (including primary and secondary adjudicated end points and quality-of-life outcomes), we only had space to present age-stratified analyses for the primary and secondary outcomes. We presented the hazard ratio (HR) for gallbladder disease in the overall cohort for each trial and noted that no significant differences by age group were observed.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




January 22, 2014
Eric Roehm, MD
1Volunteer Healthcare Clinic, Austin, Texas
JAMA. 2014;311(4):417. doi:10.1001/jama.2013.285154.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...